The stock of Universe Pharmaceuticals INC (UPC) has gone down by -18.88% for the week, with a -55.17% drop in the past month and a -85.79% drop in the past quarter. The volatility ratio for the week is 9.46%, and the volatility levels for the past 30 days are 10.43% for UPC. The simple moving average for the past 20 days is -20.37% for UPC’s stock, with a -97.98% simple moving average for the past 200 days.
Is It Worth Investing in Universe Pharmaceuticals INC (NASDAQ: UPC) Right Now?
Additionally, the 36-month beta value for UPC is 1.44.
The public float for UPC is 1.92M and currently, short sellers hold a 3.15% ratio of that float. The average trading volume of UPC on January 14, 2025 was 2.21M shares.
UPC) stock’s latest price update
Universe Pharmaceuticals INC (NASDAQ: UPC)’s stock price has dropped by -17.45 in relation to previous closing price of 0.63. Nevertheless, the company has seen a loss of -18.88% in its stock price over the last five trading days. globenewswire.com reported 2024-12-10 that New York, Dec. 10, 2024 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering (the “Offering”) of its client Universe Pharmaceuticals INC (NASDAQ: UPC) (the “Company”), a pharmaceutical producer and distributor in China.
UPC Trading at -71.33% from the 50-Day Moving Average
After a stumble in the market that brought UPC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.20% of loss for the given period.
Volatility was left at 10.43%, however, over the last 30 days, the volatility rate increased by 9.46%, as shares sank -51.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -88.87% lower at present.
During the last 5 trading sessions, UPC fell by -18.88%, which changed the moving average for the period of 200-days by -98.08% in comparison to the 20-day moving average, which settled at $0.6528. In addition, Universe Pharmaceuticals INC saw -14.75% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for UPC
Current profitability levels for the company are sitting at:
- -0.2 for the present operating margin
- 0.27 for the gross margin
The net margin for Universe Pharmaceuticals INC stands at -0.69. The total capital return value is set at -0.19. Equity return is now at value -50.22, with -30.97 for asset returns.
Based on Universe Pharmaceuticals INC (UPC), the company’s capital structure generated 0.2 points at debt to capital in total, while cash flow to debt ratio is standing at -0.93. The debt to equity ratio resting at 0.24. The interest coverage ratio of the stock is -24.75.
Currently, EBITDA for the company is -3.22 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of -0.05. The receivables turnover for the company is 1.86for trailing twelve months and the total asset turnover is 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
In conclusion, Universe Pharmaceuticals INC (UPC) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
